review - Recensione dipendente - Market Access Manager presso Amgen

3,0
20 gen 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

the nature of the pharma market in Norway is competitive

Svantaggi

conservative and restrictive reimbursement policies by government agencies are making the norwegian access environment to fall behind other countries in the EU

avatar
Risposta di Amgen
5mo
Thank you for sharing your experience. Please know that our team can be reached at AmgenCareers@careers.pure.cloud if you would like to share more about your experience. Again, thank you for taking the time to leave a review.

Esplora altre recensioni su Amgen

5,0
26 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Flexible, good compensation, great team

Svantaggi

may take meetings at odd hours due to global company

3,0
24 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Excellent compensation, benefits, and career development opportunities. Strong investment in innovation, patient-focused mission, and world-class manufacturing capabilities. The New Albany site offers exposure to complex biologics operations, large-scale capital projects, and opportunities to work alongside talented and dedicated professionals committed to delivering medicines to patients.

Svantaggi

The culture and leadership experience became increasingly inconsistent during the last year. Decision-making often lacked transparency, priorities shifted frequently, and employee feedback did not always appear to be valued. The people-centered culture that attracted many long-tenured employees seemed to drift, resulting in reduced trust, lower engagement, and increased organizational uncertainty.

Vedi recensioni per: Utile|Valutazione|Data|Tutto